NPSF Inhibitors
The acronym "NPSF" is not standard in the context of naming biochemical compounds or targets, and without further information, it's challenging to provide a detailed description of a chemical class that corresponds to this name. In the field of chemistry and biochemistry, inhibitors are typically named based on the enzyme or pathway they are known to affect, and "NPSF" does not appear to refer to a known protein, enzyme, or biochemical pathway. If "NPSF" were to be identified as a novel protein or enzyme, the development of a class of inhibitors would begin only after its discovery and subsequent characterization.
Assuming "NPSF" represents a newly discovered protein, the process of developing inhibitors would start with extensive research into the protein's structure and function. Structural biologists would seek to understand the protein's three-dimensional shape, as this is crucial for understanding how it interacts with other molecules. Techniques such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy could help elucidate the active site of the protein where potential inhibitors could bind. Bioinformatics tools might predict the protein's function by comparing its sequence to those of known proteins. With this information, a targeted approach could be taken to develop molecules that specifically inhibit the protein's activity, based on its structure and the essential features of its active site.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor which could alter chromatin structure and potentially downregulate the transcription of genes like the one encoding neuropeptide FF-amide peptide precursor. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferases, possibly leading to the demethylation and suppression of gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is another DNA methyltransferase inhibitor that may lead to reduced expression of specific genes without the toxicity associated with nucleoside analogs. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 inhibits BET bromodomain proteins, which can result in altered expression of various genes, potentially including the neuropeptide FF-amide peptide precursor gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is another DNA methyltransferase inhibitor that may lead to gene reactivation or suppression, depending on the context of the target gene's methylation status. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC inhibitor, could change the transcription of numerous genes, potentially decreasing the expression of the neuropeptide FF-amide peptide precursor. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Also known as Entinostat, MS-275 is an HDAC inhibitor that may alter gene expression profiles, including that of the neuropeptide FF-amide peptide precursor gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus, an mTOR inhibitor, could suppress the translation of many proteins, possibly including neuropeptide FF-amide peptide precursor, by reducing mTOR's role in the protein synthesis pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could disrupt downstream signaling pathways, potentially leading to altered gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor which may affect the MAPK/ERK pathway, potentially altering transcription factor activity and gene expression. | ||||||